Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Targeting myeloid leukemia stem cells.

Jordan CT.

Sci Transl Med. 2010 May 12;2(31):31ps21. doi: 10.1126/scitranslmed.3000914. Review.

PMID:
20463365
2.

Considerations for targeting malignant stem cells in leukemia.

Guzman ML, Jordan CT.

Cancer Control. 2004 Mar-Apr;11(2):97-104. Review.

3.

Right on target: eradicating leukemic stem cells.

Krause DS, Van Etten RA.

Trends Mol Med. 2007 Nov;13(11):470-81. Epub 2007 Nov 5. Review.

4.

Monoclonal antibody therapy in acute myeloid leukemia.

Feldman EJ.

Curr Hematol Rep. 2003 Jan;2(1):73-7. Review.

PMID:
12901157
5.

Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology.

ten Cate B, de Bruyn M, Wei Y, Bremer E, Helfrich W.

Curr Drug Targets. 2010 Jan;11(1):95-110. Review.

PMID:
20017722
6.

Cell surface receptor-targeted therapy of acute myeloid leukemia: a review.

Frankel AE, Sievers EL, Scheinberg DA.

Cancer Biother Radiopharm. 2000 Oct;15(5):459-76. Review.

PMID:
11155818
7.

Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells.

Majeti R.

Oncogene. 2011 Mar 3;30(9):1009-19. doi: 10.1038/onc.2010.511. Epub 2010 Nov 15. Review.

PMID:
21076471
9.

Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates.

Sievers EL.

Cancer Chemother Pharmacol. 2000;46 Suppl:S18-22. Review.

PMID:
10950142
11.

Drug delivery in acute myeloid leukemia.

Kohlschütter J, Michelfelder S, Trepel M.

Expert Opin Drug Deliv. 2008 Jun;5(6):653-63. doi: 10.1517/17425247.5.6.653 . Review.

PMID:
18532921
12.

Current uses of monoclonal antibodies in the treatment of acute leukemia.

Ruffner KL, Matthews DC.

Semin Oncol. 2000 Oct;27(5):531-9. Review.

PMID:
11049021
13.

Targeting the acute myeloid leukemia stem cells.

Krause A, Luciana M, Krause F, Rego EM.

Anticancer Agents Med Chem. 2010 Feb;10(2):104-10. Review.

PMID:
20184541
14.

Antibody-targeted therapy for myeloid leukemia.

Appelbaum FR.

Semin Hematol. 1999 Oct;36(4 Suppl 6):2-8. Review.

PMID:
10530710
15.

Native antibody and antibody-targeted chemotherapy for acute myeloid leukemia.

Sievers EL.

Adv Pharmacol. 2004;51:169-83. Review. No abstract available.

PMID:
15464909
16.

Acute myelogenous leukemia stem cells: from Bench to Bedside.

Felipe Rico J, Hassane DC, Guzman ML.

Cancer Lett. 2013 Sep 10;338(1):4-9. doi: 10.1016/j.canlet.2012.05.034. Epub 2012 Jun 17. Review.

17.

Identifying leukemia stem cells--is it feasible and does it matter?

Lutz C, Hoang VT, Buss E, Ho AD.

Cancer Lett. 2013 Sep 10;338(1):10-4. doi: 10.1016/j.canlet.2012.07.014. Epub 2012 Jul 20. Review.

PMID:
22820159
18.

Leukemia stem cells: Old concepts and new perspectives.

Mariani SA, Calabretta B.

Mol Aspects Med. 2014 Oct;39:102-9. doi: 10.1016/j.mam.2013.06.003. Epub 2013 Jun 29. Review.

PMID:
23820118
19.

Monoclonal antibodies in the treatment of myelogenous leukemias.

Scheinberg DA.

Cancer Treat Res. 1993;64:213-32. Review. No abstract available.

PMID:
7680876
20.

The potential of targeting malignant stem cells as a treatment for leukemia.

Jordan CT.

Future Oncol. 2005 Apr;1(2):205-7. Review.

PMID:
16555992

Supplemental Content

Support Center